NLGN4X (Neuroligin-4, X-linked) variants and mutations
NLGN4X (also known as Neuroligin-4, X-linked) is a human protein-coding gene encoding a neuroligin-4, X-linked protein. It contributes to synaptic adhesion and maturation, particularly in excitatory and inhibitory neural circuits. Rare X-linked loss-of-function variants have been associated with autism and intellectual disability, but variant interpretation requires care because penetrance is variable. This analysis covers 1,513 NLGN4X variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes neurodegenerative disease, hereditary disease, and autism. Example NLGN4X variants include M1?, R3L, and R3Q.
Variant analysis overview
- Gene: NLGN4X
- Protein: Neuroligin-4, X-linked
- UniProt accession: Q8N0W4
- Organism: Homo sapiens
- Variants analyzed: 1513
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 1,075 unspecified-consequence records; 269 synonymous variants; 159 missense variants; 2 in-frame deletions; 3 frameshift variants; 1 stop-gained variants; 1 splice-region variants; 3 substitution
- Prediction scores: 1,297 variants have prediction scores (86% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neurodegenerative disease, hereditary disease, autism, X-linked intellectual disability, X-linked complex neurodevelopmental disorder, insomnia, schizophrenia, Intellectual disability, autism spectrum disorder, breast carcinoma, melanoma, breast cancer.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 3 post-translational modification sites.
- Structural context: 54 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable NLGN4X variants
Examples include M1?, R3L, R3Q, R3W, P4S, Q5H, Q5L, Q5R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV9932, cosmic curated COSV99320, Variant assessed as somatic; high impact.
- R3L (p.Arg3Leu), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99321, MetaLR 0.11, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- R3Q (p.Arg3Gln), ESP rs139587269, ExAC rs139587269, TOPMed rs139587269, gnomAD rs139587269, REVEL 0.10, MetaLR 0.09
- R3W (p.Arg3Trp), rs770584895, 1000Genomes rs770584895, ExAC rs770584895, TOPMed rs770584895, REVEL 0.09, MetaLR 0.11, Variant assessed as somatic; moderate impact.
- P4S (p.Pro4Ser), rs1277406866, ClinGen CA412015664, ClinVar RCV003440907, TOPMed rs1277406866, REVEL 0.15, MetaLR 0.11, Likely benign, not provided
- Q5H (p.Gln5His), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99322, Variant assessed as somatic; moderate impact.
- Q5L (p.Gln5Leu), cosmic curated COSV52028, MetaLR 0.09, MetaSVM -1.04
- Q5R (p.Gln5Arg), TOPMed rs899519777, gnomAD rs899519777, REVEL 0.07, MetaLR 0.07
- G6* (p.Gly6Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G6A (p.Gly6Ala), cosmic curated COSV10499, MetaLR 0.12, MetaSVM -0.95
- G6R (p.Gly6Arg), NCI-TCGA TCGA novel, REVEL 0.07, MetaLR 0.11, Variant assessed as somatic; moderate impact.
- L7V (p.Leu7Val), TOPMed rs2040165438
- L8V (p.Leu8Val), ExAC rs765825856, gnomAD rs765825856, REVEL 0.07, MetaLR 0.08
- L10F (p.Leu10Phe), cosmic curated COSV10959
- P11R (p.Pro11Arg), cosmic curated COSV52011, MetaLR 0.12, MetaSVM -0.96
- P11S (p.Pro11Ser), cosmic curated COSV52002, ExAC rs769097463, TOPMed rs769097463, gnomAD rs769097463, REVEL 0.16, MetaLR 0.11
- P11T (p.Pro11Thr), ExAC rs769097463, TOPMed rs769097463, gnomAD rs769097463, REVEL 0.23, MetaLR 0.13
- L13V (p.Leu13Val), cosmic curated COSV52031
- F14L (p.Phe14Leu), NCI-TCGA TCGA novel, MetaLR 0.08, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- P16L (p.Pro16Leu), rs2519423639, ClinGen CA412015586, ClinVar RCV003886976, NCI-TCGA TCGA novel, REVEL 0.23, MetaLR 0.10, Uncertain significance, not provided
- P16S (p.Pro16Ser), cosmic curated COSV52035, TOPMed rs1289752129, gnomAD rs1289752129, REVEL 0.23, MetaLR 0.13
- P16T (p.Pro16Thr), cosmic curated COSV99034
- V17A (p.Val17Ala), rs1343544501, ClinGen CA412015581, ClinVar RCV000497444, gnomAD rs1343544501, REVEL 0.12, MetaLR 0.11, Uncertain significance, not provided
- V17F (p.Val17Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V19F (p.Val19Phe), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99321, Variant assessed as somatic; moderate impact.
- V19I (p.Val19Ile), rs1180614483, ClinGen CA412015571, NCI-TCGA Cosmic COSV9932, ClinVar RCV002288214, REVEL 0.06, MetaLR 0.09, Uncertain significance, not provided
- M20I (p.Met20Ile), rs1038013179, TOPMed rs1038013179, gnomAD rs1038013179, ClinGen CA412015558, REVEL 0.13, MetaLR 0.11, Uncertain significance, not provided
- M20L (p.Met20Leu), NCI-TCGA Cosmic COSV5202, cosmic curated COSV52029, MetaLR 0.11, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- M20T (p.Met20Thr), rs2519423501, ClinGen CA412015561, ClinVar RCV002300826, ClinVar RCV003097871, REVEL 0.10, MetaLR 0.12, Uncertain significance, Inborn genetic diseases; not provided
- S23F (p.Ser23Phe), TOPMed rs2040164478, MetaLR 0.13, MetaSVM -1.07
- N24D (p.Asn24Asp), rs1272409499, ClinGen CA412015534, ClinVar RCV003330468, AlphaMissense 0.06, MetaLR 0.17, Uncertain significance, not specified
- N24H (p.Asn24His), gnomAD rs1272409499
- N24S (p.Asn24Ser), rs775784070, ClinGen CA10341263, ClinVar RCV000999313, ExAC rs775784070, REVEL 0.05, MetaLR 0.09, Likely benign, not provided
- V25F (p.Val25Phe), cosmic curated COSV10959
- V25I (p.Val25Ile), TOPMed rs1480770358, gnomAD rs1480770358, REVEL 0.07, MetaLR 0.07
- L26F (p.Leu26Phe), NCI-TCGA Cosmic COSV5201, cosmic curated COSV52011, Variant assessed as somatic; moderate impact.
- L26P (p.Leu26Pro), gnomAD rs1324541497, REVEL 0.44, MetaLR 0.29
- T30S (p.Thr30Ser), ExAC rs778834918, gnomAD rs778834918, REVEL 0.06, MetaLR 0.15
- A31S (p.Ala31Ser), NCI-TCGA TCGA novel, REVEL 0.16, MetaLR 0.14, Variant assessed as somatic; moderate impact.
- I34M (p.Ile34Met), NCI-TCGA Cosmic COSV5200, NCI-TCGA Cosmic COSV5202, cosmic curated COSV52025, Variant assessed as somatic; moderate impact.
- I34V (p.Ile34Val), TOPMed rs2040163561, MetaLR 0.21, MetaSVM -0.85
- K35N (p.Lys35Asn), rs398124363, ClinGen CA10341258, NCI-TCGA Cosmic COSV5202, cosmic curated COSV52024, REVEL 0.10, MetaLR 0.14, Likely benign, Inborn genetic diseases
- K35R (p.Lys35Arg), TOPMed rs2040163417, REVEL 0.19, MetaLR 0.10
- K35T (p.Lys35Thr), NCI-TCGA Cosmic COSV5200, cosmic curated COSV52005, TOPMed rs2040163417, MetaLR 0.16, MetaSVM -0.99, Variant assessed as somatic; moderate impact.
- F36I (p.Phe36Ile), TOPMed rs1171452882
- F36V (p.Phe36Val), NCI-TCGA Cosmic COSV5203, cosmic curated COSV52039, MetaLR 0.08, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- T37I (p.Thr37Ile), ESP rs368982518, ExAC rs368982518, TOPMed rs368982518, gnomAD rs368982518, REVEL 0.13, MetaLR 0.14
- L38F (p.Leu38Phe), Ensembl rs868605599, REVEL 0.08, MetaLR 0.24, Uncertain significance
- L38I (p.Leu38Ile), cosmic curated COSV52021
- L38V (p.Leu38Val), Ensembl rs868605599, Uncertain significance, Inborn genetic diseases
- I39N (p.Ile39Asn), cosmic curated COSV52016, MetaLR 0.13, MetaSVM -1.00
- I39T (p.Ile39Thr), TOPMed rs1475006510, gnomAD rs1475006510, REVEL 0.25, MetaLR 0.09
- I39V (p.Ile39Val), rs201534650, ClinGen CA223595, ClinVar RCV000082030, ClinVar RCV001818250, REVEL 0.10, MetaLR 0.06, Benign
- S41N (p.Ser41Asn), rs2519423008, ClinGen CA412015422, ClinVar RCV003399539, Uncertain significance, NLGN4X-related disorder
- Q42K (p.Gln42Lys), ExAC rs779740657, TOPMed rs779740657, gnomAD rs779740657, REVEL 0.12, MetaLR 0.23, Uncertain significance, Inborn genetic diseases
- A43E (p.Ala43Glu), cosmic curated COSV10730, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A43T (p.Ala43Thr), ExAC rs757967262, TOPMed rs757967262, gnomAD rs757967262, REVEL 0.13, MetaLR 0.17, Uncertain significance, Inborn genetic diseases
- Q44E (p.Gln44Glu), gnomAD rs1345443545, REVEL 0.09, MetaLR 0.13, Uncertain significance, not provided
- Y45C (p.Tyr45Cys), TOPMed rs2040161975, MetaLR 0.21, MetaSVM -0.64
- V47I (p.Val47Ile), cosmic curated COSV52014
- N49Y (p.Asn49Tyr), cosmic curated COSV52029
- T50K (p.Thr50Lys), NCI-TCGA TCGA novel, MetaLR 0.47, MetaSVM 0.03, Variant assessed as somatic; moderate impact.
- Y52H (p.Tyr52His), ESP rs374887193, ExAC rs374887193, TOPMed rs374887193, gnomAD rs374887193, REVEL 0.32, MetaLR 0.20, Likely benign, Inborn genetic diseases
- G53R (p.Gly53Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K54E (p.Lys54Glu), Ensembl rs2040161324
- K54R (p.Lys54Arg), ESP rs372917137, TOPMed rs372917137, MetaLR 0.20, MetaSVM -0.85
- R56L (p.Arg56Leu), cosmic curated COSV10457, MetaLR 0.61, MetaSVM 0.30
- R56Q (p.Arg56Gln), 1000Genomes rs780822846, ExAC rs780822846, gnomAD rs780822846, REVEL 0.53, MetaLR 0.37
- R56W (p.Arg56Trp), NCI-TCGA TCGA novel, TOPMed rs2040161092, REVEL 0.77, MetaLR 0.67, Variant assessed as somatic; moderate impact.
- G57C (p.Gly57Cys), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99323, Variant assessed as somatic; moderate impact.
- G57S (p.Gly57Ser), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99320, Variant assessed as somatic; moderate impact.
- L58I (p.Leu58Ile), cosmic curated COSV99034, REVEL 0.03, MetaLR 0.07
- L58P (p.Leu58Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R59K (p.Arg59Lys), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99324, Variant assessed as somatic; moderate impact.
- R59S (p.Arg59Ser), rs2147702376, ClinGen CA412015302, ClinVar RCV002267315, Ensembl rs2147702376, AlphaMissense 0.45, MetaLR 0.28, Uncertain significance, not provided
- P61L (p.Pro61Leu), TOPMed rs893381534, gnomAD rs893381534, REVEL 0.18, MetaLR 0.19
- P61S (p.Pro61Ser), ExAC rs764554652, gnomAD rs764554652, REVEL 0.05, MetaLR 0.14
- P61T (p.Pro61Thr), NCI-TCGA Cosmic COSV5203, cosmic curated COSV52030, Variant assessed as somatic; moderate impact.
- L62F (p.Leu62Phe), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99321, Variant assessed as somatic; moderate impact.
- L62I (p.Leu62Ile), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99324, Variant assessed as somatic; moderate impact.
- P63S (p.Pro63Ser), ESP rs150566193, ExAC rs150566193, TOPMed rs150566193, gnomAD rs150566193, REVEL 0.10, MetaLR 0.25, Likely benign, Inborn genetic diseases
- P63T (p.Pro63Thr), rs150566193, ClinGen CA10341248, ClinVar RCV001727499, ClinVar RCV002496053, REVEL 0.14, MetaLR 0.35, Uncertain significance, Asperger syndrome, X-linked, susceptibility to, 2; Autism, susceptibility to, X
- N64H (p.Asn64His), cosmic curated COSV52030
- N64I (p.Asn64Ile), ESP rs141720696, ExAC rs141720696, TOPMed rs141720696, gnomAD rs141720696, REVEL 0.18, MetaLR 0.28, Likely benign
- N64S (p.Asn64Ser), rs141720696, ClinGen CA10341245, ClinVar RCV002410662, ESP rs141720696, REVEL 0.09, MetaLR 0.12, Likely benign, Inborn genetic diseases
- N64T (p.Asn64Thr), ESP rs141720696, ExAC rs141720696, TOPMed rs141720696, gnomAD rs141720696, REVEL 0.13, MetaLR 0.20, Likely benign
- G68C (p.Gly68Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G68V (p.Gly68Val), NCI-TCGA Cosmic COSV9931, cosmic curated COSV99319, REVEL 0.41, MetaLR 0.38, Variant assessed as somatic; moderate impact.
- P69L (p.Pro69Leu), gnomAD rs1355781670, REVEL 0.62, MetaLR 0.46
- P69S (p.Pro69Ser), rs915922545, ClinGen CA326330652, cosmic curated COSV10730, ClinVar RCV002248049, REVEL 0.49, MetaLR 0.27, Uncertain significance, not specified; not provided
- E71* (p.Glu71Ter), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99323, Variant assessed as somatic; high impact.
- Q72H (p.Gln72His), NCI-TCGA Cosmic COSV5203, cosmic curated COSV52035, REVEL 0.52, MetaLR 0.47, Variant assessed as somatic; moderate impact.
- L74V (p.Leu74Val), cosmic curated COSV10730, NCI-TCGA Cosmic COSV9932, REVEL 0.49, MetaLR 0.45, Variant assessed as somatic; moderate impact.
- G75R (p.Gly75Arg), Ensembl rs199860659
- V76I (p.Val76Ile), TOPMed rs2040159244, REVEL 0.10, MetaLR 0.05, Uncertain significance, not specified
- P77H (p.Pro77His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P77S (p.Pro77Ser), NCI-TCGA Cosmic COSV5200, cosmic curated COSV52003, MetaLR 0.67, MetaSVM 0.49, Variant assessed as somatic; moderate impact.
- A79D (p.Ala79Asp), cosmic curated COSV99034, MetaLR 0.85, MetaSVM 1.01
- S80L (p.Ser80Leu), cosmic curated COSV52022, Ensembl rs990073320, REVEL 0.06, MetaLR 0.09
- S80T (p.Ser80Thr), NCI-TCGA Cosmic COSV5203, cosmic curated COSV52030, Variant assessed as somatic; moderate impact.
- P81A (p.Pro81Ala), rs1245032090, ClinGen CA412015165, ClinVar RCV003327741, REVEL 0.25, MetaLR 0.24, Uncertain significance, not provided
- P81L (p.Pro81Leu), cosmic curated COSV52022, MetaLR 0.24, MetaSVM -0.60
- P81S (p.Pro81Ser), TOPMed rs1245032090, gnomAD rs1245032090, REVEL 0.58, MetaLR 0.56, Uncertain significance, not provided
- P81T (p.Pro81Thr), TOPMed rs1245032090, gnomAD rs1245032090, REVEL 0.66, MetaLR 0.61
- P82A (p.Pro82Ala), TOPMed rs2040158669, REVEL 0.92, MetaLR 0.85
- T83I (p.Thr83Ile), NCI-TCGA Cosmic COSV5203, cosmic curated COSV52035, NCI-TCGA Cosmic COSV9932, Variant assessed as somatic; moderate impact.
- T83L (p.Thr83Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T83N (p.Thr83Asn), NCI-TCGA Cosmic COSV5203, NCI-TCGA Cosmic COSV9932, cosmic curated COSV99321, Variant assessed as somatic; moderate impact.
- T83P (p.Thr83Pro), rs2147701921, ClinGen CA412015154, ClinVar RCV001757041, Ensembl rs2147701921, AlphaMissense 0.54, MetaLR 0.49, Uncertain significance, not provided
- G84R (p.Gly84Arg), rs746858063, ClinGen CA241778, cosmic curated COSV10499, ClinVar RCV000175929, REVEL 0.71, MetaLR 0.72, Uncertain significance, not provided
- E85D (p.Glu85Asp), ExAC rs779795912, TOPMed rs779795912, gnomAD rs779795912, NCI-TCGA TCGA novel, REVEL 0.25, MetaLR 0.13, Variant assessed as somatic; moderate impact.
- E85K (p.Glu85Lys), rs750891235, NCI-TCGA Cosmic COSV9932, cosmic curated COSV99323, Ensembl rs750891235, AlphaMissense 0.14, MetaLR 0.22, Variant assessed as somatic; moderate impact.
- R87L (p.Arg87Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R87Q (p.Arg87Gln), cosmic curated COSV10805, MetaLR 0.83, MetaSVM 0.72
- R87W (p.Arg87Trp), rs2519421979, ClinGen CA412015129, ClinVar RCV003324931, REVEL 0.89, MetaLR 0.81, Pathogenic, not provided
- F88C (p.Phe88Cys), cosmic curated COSV52036
- F88L (p.Phe88Leu), NCI-TCGA TCGA novel, MetaLR 0.85, MetaSVM 0.90, Variant assessed as somatic; moderate impact.
- F88V (p.Phe88Val), ExAC rs758104645, gnomAD rs758104645, REVEL 0.94, MetaLR 0.85
- Q89* (p.Gln89Ter), ExAC rs745466136, gnomAD rs745466136, CADD 34.00
- Q89K (p.Gln89Lys), cosmic curated COSV10499
- Q89R (p.Gln89Arg), cosmic curated COSV52040
- P90A (p.Pro90Ala), rs1473002369, ClinGen CA412015110, ClinVar RCV002453179, ClinVar RCV004763416, AlphaMissense 0.37, MetaLR 0.57, Uncertain significance, Inborn genetic diseases; not provided
- P90H (p.Pro90His), rs1199804447, gnomAD rs1199804447, REVEL 0.54, MetaLR 0.53, Variant assessed as somatic; moderate impact.
- P90T (p.Pro90Thr), gnomAD rs1473002369, REVEL 0.60, AlphaMissense 0.37
- P91Q (p.Pro91Gln), NCI-TCGA TCGA novel, MetaLR 0.74, MetaSVM 0.69, Variant assessed as somatic; moderate impact.
- P91S (p.Pro91Ser), cosmic curated COSV10877, REVEL 0.92, MetaLR 0.78
- P93S (p.Pro93Ser), Ensembl rs867795084, REVEL 0.34, MetaLR 0.33
- P94L (p.Pro94Leu), rs1057524668, ClinGen CA16609202, NCI-TCGA Cosmic COSV5203, cosmic curated COSV52033, REVEL 0.36, MetaLR 0.32, Uncertain significance, not provided
- P94S (p.Pro94Ser), cosmic curated COSV10499, TOPMed rs2040157299, MetaLR 0.44, MetaSVM 0.02
- S95P (p.Ser95Pro), NCI-TCGA Cosmic COSV5201, cosmic curated COSV52016, Variant assessed as somatic; moderate impact.
- S96F (p.Ser96Phe), cosmic curated COSV10457, gnomAD rs1220377209, REVEL 0.49, MetaLR 0.50
- S96P (p.Ser96Pro), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99323, Variant assessed as somatic; moderate impact.
- W97C (p.Trp97Cys), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99324, Variant assessed as somatic; moderate impact.
- W97L (p.Trp97Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W97R (p.Trp97Arg), cosmic curated COSV10457, MetaLR 0.67, MetaSVM 0.51
- T98A (p.Thr98Ala), rs2519421668, ClinGen CA412015059, ClinVar RCV002728406, Uncertain significance, Inborn genetic diseases
- T98I (p.Thr98Ile), TOPMed rs2040156773, MetaLR 0.15, MetaSVM -0.78
- G99V (p.Gly99Val), TOPMed rs2040156657, MetaLR 0.55, MetaSVM 0.36
- R101* (p.Arg101Ter), rs756651509, cosmic curated COSV10636, ClinGen CA10341236, ClinVar RCV000415088, CADD 32.00, Pathogenic
- R101L (p.Arg101Leu), cosmic curated COSV52034, MetaLR 0.65, MetaSVM -0.16
- R101Q (p.Arg101Gln), rs267606492, cosmic curated COSV10586, NCI-TCGA Cosmic COSV5203, Ensembl rs267606492, REVEL 0.45, MetaLR 0.52, Variant assessed as somatic; moderate impact.
- N102T (p.Asn102Thr), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99320, MetaLR 0.40, MetaSVM -0.16, Variant assessed as somatic; moderate impact.
- T103A (p.Thr103Ala), rs2519421565, ClinGen CA412015028, ClinVar RCV004493333, Likely benign, Inborn genetic diseases
- T104S (p.Thr104Ser), rs2519421526, ClinGen CA412015022, ClinVar RCV003110124, REVEL 0.51, MetaLR 0.45, Uncertain significance, not provided
- Q105K (p.Gln105Lys), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99324, Variant assessed as somatic; moderate impact.
- A107S (p.Ala107Ser), Ensembl rs866577268, MetaLR 0.05, MetaSVM -1.07
- A108G (p.Ala108Gly), rs2040156131, ClinGen CA412014993, ClinVar RCV002281450, TOPMed rs2040156131, REVEL 0.18, MetaLR 0.26, Uncertain significance, not provided
- C110F (p.Cys110Phe), cosmic curated COSV10499, MetaLR 0.82, MetaSVM 0.95
- P111L (p.Pro111Leu), NCI-TCGA Cosmic COSV5201, cosmic curated COSV52016, REVEL 0.57, MetaLR 0.41, Variant assessed as somatic; moderate impact.
- Q112E (p.Gln112Glu), NCI-TCGA Cosmic COSV5203, cosmic curated COSV52034, Variant assessed as somatic; moderate impact.
- Q112P (p.Gln112Pro), cosmic curated COSV52033
- H113N (p.His113Asn), NCI-TCGA TCGA novel, MetaLR 0.12, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- L114P (p.Leu114Pro), rs2519421291, ClinGen CA412014953, ClinVar RCV003328798, Uncertain significance, not provided
- L114Q (p.Leu114Gln), NCI-TCGA Cosmic COSV5200, cosmic curated COSV52008, MetaLR 0.40, MetaSVM -0.20, Variant assessed as somatic; moderate impact.
- D115G (p.Asp115Gly), NCI-TCGA TCGA novel, MetaLR 0.25, MetaSVM -0.54, Variant assessed as somatic; moderate impact.
- E116D (p.Glu116Asp), ExAC rs753390003, TOPMed rs753390003, gnomAD rs753390003, MetaLR 0.20, MetaSVM -0.86
- R117T (p.Arg117Thr), gnomAD rs1206070204, REVEL 0.32, MetaLR 0.11
- S118A (p.Ser118Ala), ExAC rs764752836, TOPMed rs764752836, gnomAD rs764752836
- S118T (p.Ser118Thr), ExAC rs764752836, TOPMed rs764752836, gnomAD rs764752836, REVEL 0.11, MetaLR 0.12
- S118Y (p.Ser118Tyr), gnomAD rs977524047, REVEL 0.17, MetaLR 0.13
- L119F (p.Leu119Phe), cosmic curated COSV10959
- L119S (p.Leu119Ser), cosmic curated COSV52027
- L120M (p.Leu120Met), NCI-TCGA Cosmic COSV5200, cosmic curated COSV52004, Variant assessed as somatic; moderate impact.
- L120P (p.Leu120Pro), Ensembl rs2147701245, REVEL 0.12, MetaLR 0.09
- H121R (p.His121Arg), TOPMed rs1405905840, gnomAD rs1405905840, REVEL 0.16, MetaLR 0.07
- D122G (p.Asp122Gly), Ensembl rs2040155213
- D122N (p.Asp122Asn), cosmic curated COSV52038, MetaLR 0.14, MetaSVM -0.93
- P125A (p.Pro125Ala), TOPMed rs1322873473
- P125L (p.Pro125Leu), rs1347582887, ClinGen CA412014876, ClinVar RCV003231733, ClinVar RCV004961244, REVEL 0.58, MetaLR 0.48, Uncertain significance, Inborn genetic diseases; not provided
- W127C (p.Trp127Cys), NCI-TCGA TCGA novel, cosmic curated COSV10499, Variant assessed as somatic; high impact.
- W127R (p.Trp127Arg), NCI-TCGA TCGA novel, MetaLR 0.44, MetaSVM -0.09, Variant assessed as somatic; moderate impact.
- F128L (p.Phe128Leu), NCI-TCGA Cosmic COSV5201, cosmic curated COSV52015, MetaLR 0.31, MetaSVM -0.56, Variant assessed as somatic; moderate impact.
- F128Y (p.Phe128Tyr), ExAC rs753149396, gnomAD rs753149396, REVEL 0.27, MetaLR 0.19
- A130T (p.Ala130Thr), rs1029475096, NCI-TCGA Cosmic COSV5201, cosmic curated COSV52010, gnomAD rs1029475096, REVEL 0.16, MetaLR 0.20, Variant assessed as somatic; moderate impact.
- A130V (p.Ala130Val), NCI-TCGA TCGA novel, MetaLR 0.19, MetaSVM -0.80, Variant assessed as somatic; moderate impact.
- N131S (p.Asn131Ser), rs145307351, ClinGen CA10341230, ClinVar RCV001528731, ESP rs145307351, REVEL 0.16, MetaLR 0.21, Likely benign, not provided
- D133N (p.Asp133Asn), NCI-TCGA Cosmic COSV9932, cosmic curated COSV99321, MetaLR 0.10, MetaSVM -1.09, Variant assessed as somatic; moderate impact.
- T134A (p.Thr134Ala), rs774379413, ExAC rs774379413, TOPMed rs774379413, gnomAD rs774379413, REVEL 0.06, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- T134I (p.Thr134Ile), gnomAD rs1405089218, REVEL 0.12, MetaLR 0.11
- T134S (p.Thr134Ser), NCI-TCGA Cosmic COSV5201, cosmic curated COSV52013, MetaLR 0.10, MetaSVM -1.04, Variant assessed as somatic; moderate impact.
Public NLGN4X analysis runs
- NLGN4X analysis run — NLGN4X (1,513 variants) — completed 2026-08-19